DK175507B1 - N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater - Google Patents

N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater Download PDF

Info

Publication number
DK175507B1
DK175507B1 DK198803248A DK324888A DK175507B1 DK 175507 B1 DK175507 B1 DK 175507B1 DK 198803248 A DK198803248 A DK 198803248A DK 324888 A DK324888 A DK 324888A DK 175507 B1 DK175507 B1 DK 175507B1
Authority
DK
Denmark
Prior art keywords
alkyl
formula
group
acid
staurosporine
Prior art date
Application number
DK198803248A
Other languages
Danish (da)
English (en)
Other versions
DK324888D0 (da
DK324888A (da
Inventor
Giorgio Caravatti
Andreas Fredenhagen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK324888D0 publication Critical patent/DK324888D0/da
Publication of DK324888A publication Critical patent/DK324888A/da
Application granted granted Critical
Publication of DK175507B1 publication Critical patent/DK175507B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK198803248A 1987-06-15 1988-06-14 N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater DK175507B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH224487 1987-06-15
CH224487 1987-06-15
CH144088 1988-04-19
CH144088 1988-04-19

Publications (3)

Publication Number Publication Date
DK324888D0 DK324888D0 (da) 1988-06-14
DK324888A DK324888A (da) 1988-12-16
DK175507B1 true DK175507B1 (da) 2004-11-15

Family

ID=25687663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803248A DK175507B1 (da) 1987-06-15 1988-06-14 N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater

Country Status (20)

Country Link
EP (1) EP0296110B1 (hu)
JP (1) JP2708047B2 (hu)
KR (1) KR970001529B1 (hu)
AT (1) ATE134375T1 (hu)
AU (1) AU617324B2 (hu)
CA (1) CA1337763C (hu)
DE (1) DE3855015D1 (hu)
DK (1) DK175507B1 (hu)
ES (1) ES2083956T3 (hu)
FI (1) FI89362C (hu)
GR (1) GR3019064T3 (hu)
HK (1) HK1003788A1 (hu)
HU (1) HU201329B (hu)
IE (1) IE70523B1 (hu)
IL (1) IL86632A0 (hu)
MY (1) MY104316A (hu)
NO (1) NO170634C (hu)
NZ (1) NZ225018A (hu)
PT (1) PT87719B (hu)
YU (1) YU115488A (hu)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ucn―01
EP0383919A4 (en) * 1988-02-04 1992-08-05 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
USRE36736E (en) * 1989-02-06 2000-06-13 Hoffman-La Roche Inc. Substituted pyrroles
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
AU2866992A (en) * 1991-10-10 1993-05-03 Schering Corporation 4'-(n-substituted-n-oxide)staurosporine derivatives
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO1993018771A1 (fr) * 1992-03-24 1993-09-30 Asahi Kasei Kogyo Kabushiki Kaisha INHIBITEUR DE L'AGGLUTINATION PLAQUETTAIRE CONTENANT UN DERIVE DE STAUROSPORINE η-LACTAME
US5621100A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. K-252a derivatives for treatment of neurological disorders
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
CA2123895A1 (en) * 1992-09-21 1994-03-31 Tatsuya Tamaoki A therapeutic agent for thrombocytopenia
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP2324829A1 (en) 1993-01-28 2011-05-25 Boston Scientific Limited Therapeutic inhibitors of vascular smooth muscle cells
PH30300A (en) * 1993-05-07 1997-01-20 Ciba Geigy Ag Polycyclic compounds and processes for the preparation thereof
AU7080994A (en) * 1993-07-09 1995-02-06 Institute Of Cancer Research, The Protein tyrosine kinase and ligands thereof
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
US6184217B1 (en) 1996-06-25 2001-02-06 Cephalon, Inc. Use of K-252a derivative
BR9808109A (pt) 1997-03-31 2000-03-08 Neorx Corp Inibidor terapêutico de células vasculares da musculatura lisa
ES2211197T3 (es) * 1998-11-23 2004-07-01 Novartis Ag Uso de derivados de estaurosporina para tratar enfermedades neovasculares oculares.
SI3351246T1 (sl) 2001-02-19 2019-08-30 Novartis Pharma Ag Derivat rapamicina za zdravljenje trdnega tumorja, povezanega z deregulirano angiogenezo
US20040167134A1 (en) 2001-05-16 2004-08-26 Christian Bruns Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
WO2003037347A1 (en) 2001-10-30 2003-05-08 Novartis Ag Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
JP5227492B2 (ja) 2002-05-16 2013-07-03 ノバルティス アーゲー 癌におけるedgレセプター結合剤の使用
CN101897662B (zh) * 2002-07-23 2013-05-22 诺瓦提斯公司 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
PE20050158A1 (es) 2003-05-19 2005-05-12 Irm Llc Compuestos inmunosupresores y composiciones
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
US20070191338A1 (en) 2003-08-08 2007-08-16 Atadja Peter W Combinations comprising staurosporines
TW200538433A (en) 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
BRPI0514765A (pt) * 2004-08-31 2008-06-24 Novartis Ag compostos orgánicos
JO2897B1 (en) * 2004-11-05 2015-09-15 نوفارتيس ايه جي Organic compounds
NZ568182A (en) 2005-11-21 2010-08-27 Novartis Ag Neuroendocrine tumor treatment using MTOR inhibitors
KR20110101159A (ko) 2008-12-18 2011-09-15 노파르티스 아게 신규 염
RU2518114C3 (ru) 2008-12-18 2021-11-24 Новартис Аг Гемифумаратная соль 1-[4-[1-(4-циклогексил-3-трифторметилбензилоксиимино)этил]-2-этилбензил] азетидин-3-карбоновой кислоты
BRPI0922457A2 (pt) 2008-12-18 2015-12-15 Novartis Ag forma polimórfica de ácido 1-(4-{1-[(e)-4-ciclo-hexil-3-trifluormetil-benziloxi-imino]-etil)-2-etil-benzil)-azetidino-3-carboxílico"
EP2327706A1 (en) 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013167403A1 (en) 2012-05-09 2013-11-14 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
EP4058465A1 (en) 2019-11-14 2022-09-21 Cohbar Inc. Cxcr4 antagonist peptides
IT202000004291A1 (it) * 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN112812129A (zh) * 2020-12-31 2021-05-18 浙江海正药业股份有限公司 米哚妥林的新晶型及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383919A4 (en) * 1988-02-04 1992-08-05 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives

Also Published As

Publication number Publication date
YU115488A (en) 1989-12-31
PT87719A (pt) 1988-07-01
CA1337763C (en) 1995-12-19
EP0296110A2 (de) 1988-12-21
KR970001529B1 (ko) 1997-02-11
JP2708047B2 (ja) 1998-02-04
AU617324B2 (en) 1991-11-28
FI89362C (fi) 1993-09-27
IE881787L (en) 1988-12-15
KR890000494A (ko) 1989-03-15
HK1003788A1 (en) 1998-11-06
FI882808A0 (fi) 1988-06-13
PT87719B (pt) 1992-10-30
EP0296110B1 (de) 1996-02-21
EP0296110A3 (de) 1991-02-27
DK324888D0 (da) 1988-06-14
NZ225018A (en) 1990-09-26
DE3855015D1 (de) 1996-03-28
DK324888A (da) 1988-12-16
ATE134375T1 (de) 1996-03-15
MY104316A (en) 1994-03-31
AU1757188A (en) 1988-12-15
IE70523B1 (en) 1996-12-11
NO170634C (no) 1992-11-11
ES2083956T3 (es) 1996-05-01
NO882613D0 (no) 1988-06-14
HU201329B (en) 1990-10-28
FI89362B (fi) 1993-06-15
NO882613L (no) 1988-12-16
IL86632A0 (en) 1988-11-30
FI882808A (fi) 1988-12-16
HUT47587A (en) 1989-03-28
JPS6434989A (en) 1989-02-06
NO170634B (no) 1992-08-03
GR3019064T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
DK175507B1 (da) N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater
US5093330A (en) Staurosporine derivatives substituted at methylamino nitrogen
EP0148725B1 (en) Sulfonamido-benzamide derivatives
JP2010502617A (ja) 抗菌物質として有用なヒダントイン誘導体
TW202321251A (zh) 新穎螺環吡咯啶衍生的抗病毒劑
ZA200409053B (en) (S)-4-Amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamin de, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor.
JP2019505532A (ja) Tlr7アゴニストのマレイン酸塩、その結晶形c、d及びe、マレイン酸塩及び結晶形の調製方法及び使用
NO314730B1 (no) Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og anvendelse derav til fremstilling av preparater, samt anti-AIDS-middelog fremgangsmåte for fremstilling av slike forbindelser
CN113072497A (zh) 蛋白酶抑制剂、其制备和用途
WO2006101454A1 (en) Benzothiophene derivatives: preparation and pharmaceutical applications
RU2162470C2 (ru) 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения
NZ248737A (en) 5-oxo-dibenzo[a,d]cycohepta-1,4-dienes and medicaments thereof
JP4486892B2 (ja) ペプチドデホルミラーゼ阻害剤
CN110117293B (zh) 多氟取代的Largazole类似物、其制备方法和用途
KR890002085B1 (ko) 디히드로오로트산 유도체의 제조방법
JP2848538B2 (ja) 2環性アミノ基で置換されたピリドンカルボン酸誘導体、そのエステルおよびその塩ならびにこれらの中間体たる2環性アミン
JP2006523612A (ja) ペプチドデホルミラーゼ阻害剤
WO1997005140A1 (en) Trindene compounds
WO2016107227A1 (zh) 吡咯酰胺类化合物及其制备方法与用途
IE852939L (en) Benzamide derivatives
NO328933B1 (no) Peptid-deformylaseinhibitorer
DD281808A5 (de) Verfahren zur herstellung n-substituierter derivate von staurosporin
CN117164524A (zh) 具有parp7/hdac双靶点抑制活性的哒嗪酮衍生物及其制备方法和应用
HRP940452A2 (en) Derivatives, substituted for the methylamino nitrogen
WO1997005141A1 (en) Staurosporine analogues

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHS Application shelved for other reasons than non-payment
PUP Patent expired